Miles W. Carroll

Institute of Human Genetics — Poland

Medicine · Health Sciences

85h-index39.1kcitations366works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(142), Viral Infections and Outbreaks Research(84), COVID-19 Clinical Research Studies(81), Viral Infections and Vectors(66), Immunotherapy and Immune Responses(39)

Publications353 total

Current knowledge on the host-pathogen interactions of henipaviruses and novel platforms to enable further characterisation
EBioMedicine·2026Open Access
ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation
Vaccine·2025Open Access
The pharmacokinetics, bio-distribution and therapeutic efficacy of a trimeric nanobody against SARS-CoV-2 in the Syrian golden hamster COVID-19 model
2025Open Access
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity
Scientific Reports·2025Open Access
Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection
Journal of Virology·2025· 1 citedOpen Access
Phylogenetic analysis of initial Ebola virus genomes from the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo, September 2025
2025Open Access
Divergent antibody-mediated population immunity to H5, H7 and H9 subtype potential pandemic influenza viruses
2025Open Access
Evaluation of location tracking methods to understand human-wildlife contact and pathogen spillover risks
2025Open Access
Drivers of Crimean-Congo Hemorrhagic Fever in Natural Host and Effects of Control Measures, Bulgaria
Emerging infectious diseases·2025Open Access
Hamsters immunized with formalin-inactivated SARS-CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection
npj Vaccines·2025Open Access
Ebola virus persistence: implications for human-to-human transmission and new outbreaks
Exploration of Medicine·2025· 1 citedOpen Access
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management
Journal of Virology·2025· 2 citedOpen Access
Longitudinal Immunoprofiling of the CD8+ T-Cell Response in SARS-CoV-2 mRNA Vaccinees and COVID-19 Patients
Vaccines·2025Open Access
A systems biology approach to define SARS-CoV-2 correlates of protection
npj Vaccines·2025· 2 citedOpen Access
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal immunity– an observational cohort study
2025Open Access
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
European Journal of Medicinal Chemistry·2025· 3 citedOpen Access
Spermidine Mitigates Immune Cell Senescence, Enhances Autophagy, and Boosts Vaccine Responses in Healthy Older Adults.
2025· 2 citedOpen Access
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals
Nature Communications·2025· 8 citedOpen Access
Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic
Microbiology Spectrum·2025· 5 citedOpen Access
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time
Nucleic Acids Research·2025· 2 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Christina Dold(15), Eleanor Barnes(14), Karen R. Buttigieg(13), Andrew J. Pollard(12), Donal Skelly(12), Paul Klenerman(12), Juthathip Mongkolsapaya(12), David I. Stuart(12), Gavin Screaton(12), Piyada Supasa(11), Alexander J. Mentzer(10), Helen M. E. Duyvesteyn(10), Sagida Bibi(9), Naomi S. Coombes(9), Daming Zhou(9), Julian C. Knight(9), Derrick W. Crook(9), William James(9), Jingshan Ren(9), Sophie Duraffour(9)